{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T16:14:26Z","timestamp":1787933666485,"version":"build-2784847793"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain, Behavior, and Immunity"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1016\/j.bbi.2016.05.006","type":"journal-article","created":{"date-parts":[[2016,5,12]],"date-time":"2016-05-12T14:42:16Z","timestamp":1463064136000},"page":"53-57","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Effect of recombinant erythropoietin on inflammatory markers in patients with affective disorders: A randomised controlled study"],"prefix":"10.1016","volume":"57","author":[{"given":"Maj","family":"Vinberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pia","family":"Weikop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niels Vidiendal","family":"Olsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars Vedel","family":"Kessing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamilla","family":"Miskowiak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbi.2016.05.006_b0005","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1385\/JMN:25:2:183","article-title":"Recombinant erythropoietin down-regulates IL-6 and CXCR4 genes in TNF-alpha-treated primary cultures of human microvascular endothelial cells: implications for multiple sclerosis","volume":"25","author":"Avasarala","year":"2005","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.bbi.2016.05.006_b0010","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1517\/14728222.2013.780599","article-title":"Targeting erythropoietin for chronic neurodegenerative diseases","volume":"17","author":"Chong","year":"2013","journal-title":"Exp. Opin. Ther. Targets"},{"key":"10.1016\/j.bbi.2016.05.006_b0015","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.jad.2013.04.039","article-title":"Elevated C-reactive protein and cognitive deficits in individuals with bipolar disorder","volume":"150","author":"Dickerson","year":"2013","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.bbi.2016.05.006_b0020","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1053\/j.jrn.2007.10.029","article-title":"Recombinant human erythropoietin in the treatment of human brain disease: focus on cognition","volume":"18","author":"Ehrenreich","year":"2008","journal-title":"J. Renal Nutr."},{"key":"10.1016\/j.bbi.2016.05.006_b0025","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1159\/000201934","article-title":"Reliability and validity of the Massachusetts general hospital cognitive and physical functioning questionnaire","volume":"78","author":"Fava","year":"2009","journal-title":"Psychother. Psychosom."},{"key":"10.1016\/j.bbi.2016.05.006_b0030","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.cell.2012.07.001","article-title":"The dawn of virtual cell biology","volume":"150","author":"Freddolino","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.bbi.2016.05.006_b0035","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1089\/cap.2011.0009","article-title":"Preliminary findings regarding proinflammatory markers and brain-derived neurotrophic factor among adolescents with bipolar spectrum disorders","volume":"21","author":"Goldstein","year":"2011","journal-title":"J. Child Adolesc. Psychopharmacol."},{"key":"10.1016\/j.bbi.2016.05.006_b0040","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.cyto.2008.12.005","article-title":"Erythropoietin augments the cytokine response to acute endotoxin-induced inflammation in humans","volume":"45","author":"Hojman","year":"2009","journal-title":"Cytokine"},{"key":"10.1016\/j.bbi.2016.05.006_b0045","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1517\/17425255.2013.731394","article-title":"GLP-1 agonists for type 2 diabetes: pharmacokinetic and toxicological considerations","volume":"9","author":"Jespersen","year":"2013","journal-title":"Exp. Opin. Drug Metab. Toxicol."},{"key":"10.1016\/j.bbi.2016.05.006_b0050","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1111\/j.1472-8206.2011.00992.x","article-title":"Evaluation of the effect of one large dose of erythropoietin against cardiac and cerebral ischemic injury occurring during cardiac surgery with cardiopulmonary bypass: a randomized double-blind placebo-controlled pilot study","volume":"26","author":"Joyeux-Faure","year":"2012","journal-title":"Fundam. Clin. Pharmacol."},{"key":"10.1016\/j.bbi.2016.05.006_b0055","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.neubiorev.2014.12.017","article-title":"Is there a \u201cmetabolic-mood syndrome\u201d? A review of the relationship between obesity and mood disorders","volume":"52","author":"Mansur","year":"2015","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.bbi.2016.05.006_b0060","doi-asserted-by":"crossref","first-page":"9617","DOI":"10.1073\/pnas.1200554109","article-title":"Erythropoietin-induced changes in brain gene expression reveal induction of synaptic plasticity genes in experimental stroke","volume":"109","author":"Mengozzi","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.bbi.2016.05.006_b0065","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.13m08839","article-title":"Recombinant human erythropoietin to target cognitive dysfunction in bipolar disorder: a double-blind, randomized, placebo-controlled phase 2 trial","author":"Miskowiak","year":"2014","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.bbi.2016.05.006_b0070","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1038\/npp.2013.335","article-title":"Recombinant human erythropoietin for treating treatment-resistant depression: a double-blind, randomized, placebo-controlled phase 2 trial","volume":"39","author":"Miskowiak","year":"2014","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.bbi.2016.05.006_b0075","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1016\/S0140-6736(15)00386-4","article-title":"Erythropoietin in traumatic brain injury (EPO-TBI): a double-blind randomised controlled trial","volume":"386","author":"Nichol","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.bbi.2016.05.006_b0080","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1186\/s13054-014-0526-9","article-title":"Erythropoietin and organ protection: lessons from negative clinical trials","volume":"18","author":"Pearl","year":"2014","journal-title":"Crit. Care"},{"key":"10.1016\/j.bbi.2016.05.006_b0085","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1097\/01.nmd.0000110280.19284.47","article-title":"Assessing past treatment history: test\u2013retest reliability of the Treatment Response to Antidepressant Questionnaire","volume":"192","author":"Posternak","year":"2004","journal-title":"J. Nerv. Ment. Dis."},{"key":"10.1016\/j.bbi.2016.05.006_b0090","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1053\/j.jvca.2008.08.018","article-title":"Two large preoperative doses of erythropoietin do not reduce the systemic inflammatory response to cardiac surgery","volume":"23","author":"Poulsen","year":"2009","journal-title":"J. Cardiothorac. Vasc. Anesth."},{"key":"10.1016\/j.bbi.2016.05.006_b0095","doi-asserted-by":"crossref","first-page":"19","DOI":"10.2217\/bmm.11.108","article-title":"High-sensitive C-reactive protein: universal prognostic and causative biomarker in heart disease?","volume":"6","author":"Rietzschel","year":"2012","journal-title":"Biomark. Med."},{"key":"10.1016\/j.bbi.2016.05.006_b0100","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/WCO.0b013e32835c4f04","article-title":"Vascular cognitive impairment","volume":"26","author":"Rincon","year":"2013","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.bbi.2016.05.006_b0105","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.jad.2015.08.058","article-title":"Inflammation as a neurobiological substrate of cognitive impairment in bipolar disorder: evidence, pathophysiology and treatment implications","volume":"188","author":"Rosenblat","year":"2015","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.bbi.2016.05.006_b0110","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.neubiorev.2015.12.004","article-title":"Neuroinflammation negatively affects adult hippocampal neurogenesis and cognition: can exercise compensate?","volume":"61","author":"Ryan","year":"2015","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.bbi.2016.05.006_b0115","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.ejphar.2012.07.018","article-title":"Erythropoietin attenuated vascular dysfunction and inflammation by inhibiting NADPH oxidase-derived superoxide production in nitric oxide synthase-inhibited hypertensive rat aorta","volume":"691","author":"Toba","year":"2012","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bbi.2016.05.006_b0120","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.molimm.2015.01.011","article-title":"Erythropoietin acts as an anti-inflammatory signal on murine mast cells","volume":"65","author":"Wiedenmann","year":"2015","journal-title":"Mol. Immunol."}],"container-title":["Brain, Behavior, and Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889159116301143?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889159116301143?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T07:44:25Z","timestamp":1760168665000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889159116301143"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":24,"alternative-id":["S0889159116301143"],"URL":"https:\/\/doi.org\/10.1016\/j.bbi.2016.05.006","relation":{},"ISSN":["0889-1591"],"issn-type":[{"value":"0889-1591","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of recombinant erythropoietin on inflammatory markers in patients with affective disorders: A randomised controlled study","name":"articletitle","label":"Article Title"},{"value":"Brain, Behavior, and Immunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbi.2016.05.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}